Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. - Wikidata - wikimedia - TriplyDB

Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.

Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.

http://www.wikidata.org/entity/Q34570144

about

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications Role of the PD-1 pathway in the immune response Immunoregulation in Fungal Diseases Cutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models Both PD-1 ligands protect the kidney from ischemia reperfusion injury.Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection.Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.PD-1, gender, and autoimmunity.Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function.Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice.Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment.Hepatic stellate cells: central modulators of hepatic carcinogenesis.Molecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration.HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).Up-regulated S100 calcium binding protein A8 in Plasmodium-infected patients correlates with CD4(+)CD25(+)Foxp3 regulatory T cell generation.B7 family molecules as regulators of the maternal immune system in pregnancy HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke.The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome.Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies.Dendritic cells: a critical player in cancer therapy?The complex role of B7 molecules in tumor immunology Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus Soluble programmed cell death receptor-1 (sPD-1): a potential biomarker with anti-inflammatory properties in human and experimental acute respiratory distress syndrome (ARDS).Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen.Role of dendritic cells in the induction of regulatory T cells.Therapeutic targeting of B7-H1 in breast cancer.Tumor-associated macrophages: from mechanisms to therapy.Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke.Harnessing the properties of dendritic cells in the pursuit of immunological tolerance.Dendritic cells as gatekeepers of tolerance.Immunoregulatory functions of VISTA.The function of myeloid dendritic cells in rheumatoid arthritis.Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course.PD-L2 negatively regulates Th1-mediated immunopathology during Fasciola hepatica infection.

P2860

Q26764855-A5A89565-C606-4E3D-8473-219E4AE4D960 Q26828748-FB0B652F-97E0-45B3-8463-010AE3A1A60B Q28074776-9BAAF844-8A5A-4132-B973-EC957789CDBC Q28592282-62D7A440-5125-465C-A2AF-7DF1BFD11AEB Q30301290-E2439FA7-0AFF-42BF-88FA-C7279774034F Q30417431-267C8225-69A2-439D-B793-78E761AB1BBC Q33601667-C0CD455F-479D-46F6-8008-46A7C5FCE94A Q33685495-92161EB9-5EEC-4AF6-B159-7CFE40EC361C Q33910421-E60F6841-EC18-4F70-BCE2-970407524100 Q34589567-FE7E57A2-7790-4052-88B6-B39463C0001E Q34691304-D203F2E5-6167-43CA-B161-6A12025287D3 Q34788681-BA064275-3E7E-4806-8235-781650FA04AD Q35094493-5F133E6C-7C13-4152-98F6-AE8D0B100565 Q35102253-CF1EA5BD-8FDC-4934-8749-BCC6A162D487 Q35137584-C18FEF03-0FDE-4B1B-9FE1-686FEB8A27CC Q35151883-CC83959C-1E69-4D16-9394-081864EEA0CB Q35642468-FE13E63F-CD6C-41CE-BFB7-0B10C922503E Q35875231-EE708AB6-6C35-45EB-8CE7-0F57C830E654 Q35886890-03F1976F-77DD-471B-BC8D-D2FC34652E59 Q36126345-958E91B1-3E73-44F2-9F73-A2A72112E7F8 Q36185034-34985501-EFDB-4619-8C1C-02BE68432AF5 Q36238411-CF8C0B52-D999-457C-9B21-5872E52E645A Q36408695-6D54753E-2E24-4E02-8487-9773459FB714 Q36483852-B0E168E4-8824-476B-8179-F8AEA614772C Q36522770-16593A4E-0B36-4F3B-9F80-F4A4D3E86C10 Q37276138-2FC42626-7890-48B4-9BCC-1F777861E2FF Q37304913-26484E4E-8D79-4847-9CE1-B37FA0688972 Q37316252-CF6DFBFC-FE43-46D6-A89A-662D0CD37FFB Q37410422-C961229F-FACC-443F-9408-AB7B60C088AF Q37740679-C6E57D92-319D-4F1F-85E2-683B60144185 Q37895356-16D8C0A9-88A0-4669-8BCF-B66D868F3F17 Q37922793-25479D35-BA45-4341-94F9-BC9563DC9C3C Q38230880-00715D22-0B92-46F0-B798-35B7B75FF10E Q38273234-D43021EE-000E-4620-9E64-0D1D66824CA5 Q38682156-E2C5CF69-AB3B-4E46-A0A1-AD4ED06E0D9A Q38908238-1309F1D9-E506-4028-90B0-2BCEBA07C505 Q38930123-8665A8ED-97DE-4CFE-8DB5-9E29CDB7431F Q39150111-37745D15-4E3B-463A-AF8D-3645553594CE Q39172891-B5740D50-0DB2-4045-A0EC-FAE8B3D693CB Q39247154-1659C794-CFD4-4CAF-80C6-90452A95A0CE

P2860

Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.

http://www.wikidata.org/entity/Q34570144

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.

@ast

Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.

@en

Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.

@nl

type

label

Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.

@ast

Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.

@en

Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.

@nl

prefLabel

Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.

@ast

Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.

@en

Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.

@nl

P1433

Q34570144-E5FF603F-4889-4E31-8A87-2AABC8FC088E

P1476

Q34570144-D4FCD581-A5F6-4E8E-8EED-D24BFC442B66

P2093

Q34570144-013A979A-6665-47C7-BC62-3381BEA23F08

Q34570144-134C1127-1254-44D6-9898-1915B2FD9DB3

Q34570144-8C58AB27-503F-48B4-8325-B966F7538BC8

Q34570144-937F98D2-3AFC-4916-B2EC-BB4374AE8FF8

Q34570144-A15D545A-D4DF-4BD7-8BB7-B84F5BB1C2E1

Q34570144-C2AC84F1-0F7A-4030-A1BA-7477CFEA715A

Q34570144-C85D7443-D3DE-4340-AC30-71E61D18BA57

Q34570144-F55FD858-FA44-424A-8870-40E69BE448C6

P2860

Q34570144-49485B93-CE9B-40B2-A513-2CD6B729BF3F

Q34570144-64F18F65-7C6C-4A90-89FF-052D59624BCA

Q34570144-66C24D8F-6B9F-4CEC-B0D2-48FE141207A0

Q34570144-821820D5-56BE-4E9E-9804-35475CFC2787

Q34570144-A2B39D5F-3027-44DC-93E6-997A7F237681

Q34570144-A61D7EE8-85AE-4F28-BEB0-69D5E7EDEC1D

Q34570144-A75AAF4C-F5D6-48AC-8C20-837266B6891F

Q34570144-B64617E4-A8DC-4A66-8900-E349705B2F6D

Q34570144-F81C3F72-AF77-417F-B79C-E136CE528F96

Q34570144-F9A8370D-5108-4A8C-AAE5-10D71C774F61

P304

Q34570144-9C2A1A2A-59A2-442F-9370-9DC210489581

P31

Q34570144-C1F294B3-5DC3-4707-91A3-30AA9EE19176

P356

Q34570144-675EC359-9ACC-44C5-A23A-1B2F1660E7FB

P407

Q34570144-34381356-804E-4090-9860-FC9A95B4AACB

P433

Q34570144-4B324F98-D7C9-4AAF-BDCB-B7DC5387252F

P478

Q34570144-4933F933-C946-4BC0-A573-129F1915C6C7

P577

Q34570144-DB41FDFC-1459-44D7-994D-6BE43FE65DA9

P5875

Q34570144-392C5B9D-821F-47AB-8A70-294A554D5558

P698

Q34570144-42A99433-00C3-407C-A3B7-E3386F504555

P356

P1433

European Journal of Immunology

P1476

Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.

@en

P2093

Anthony J Coyle

http://www.w3.org/2001/XMLSchema#string

Bart N Lambrecht

http://www.w3.org/2001/XMLSchema#string

Daniëlle Hijdra

http://www.w3.org/2001/XMLSchema#string

Femke Muskens

http://www.w3.org/2001/XMLSchema#string

Friso B J van Assema

http://www.w3.org/2001/XMLSchema#string

Harmjan Kuipers

http://www.w3.org/2001/XMLSchema#string

Henk C Hoogsteden

http://www.w3.org/2001/XMLSchema#string

Monique Willart

http://www.w3.org/2001/XMLSchema#string

P2860

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses

Expression of programmed death 1 ligands by murine T cells and APC

B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.

T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression

Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.

Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.

Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine.

Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages.

Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells.

P304

2472-2482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJI.200635978

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6870077

http://www.w3.org/2001/XMLSchema#string

P698

16917960

http://www.w3.org/2001/XMLSchema#string